AlloVir

0 followers

‌

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Industries

Headquarters

Houston, United States

Employees

Links

Org chart

Chief Scientific Officer

Ann Leen

Collapse

Vp, Biometrics

Executive Director, R&d Counsel

Francesca Cardarelli

Senior Medical Director Clinical Development

Jennifer Leung Imura

Director, Clinical, Medical And Regulatory Affairs IT Business Partner

Julie Mabalot Luk

Director, Clinical Operations And Early Portfolio Management

President and Chief Financial Officer

Teams

Regulatory Affairs Team

14 members

Leadership Team

2 members

Clinical Operations Team

3 members

Similar companies

Kura Oncology

18 followers

Adverum Biotech

8 followers

SpringWorks Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Viridian Therapeutics

2 followers

Fortis Life Sciences

1 follower

Vividion Therapeutics

1 follower

Biosynth

1 follower

Nkarta

1 follower

TMRW Life Sciences

1 follower

Explore companies